Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.

Ibrahim, N K

Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer. [electronic resource] - American journal of clinical oncology Apr 2000 - 117-21 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

0277-3732

10.1097/00000421-200004000-00003 doi


Adult
Aged
Antineoplastic Agents, Phytogenic--administration & dosage
Breast Neoplasms--drug therapy
Dose-Response Relationship, Drug
Female
Humans
Infusions, Intravenous
Middle Aged
Vinblastine--administration & dosage
Vinorelbine